Calcium release-activated calcium (CRAC) channels mediate the β2-adrenergic regulation of Na,K-ATPase  by Keller, Michael J. et al.
FEBS Letters 588 (2014) 4686–4693journal homepage: www.FEBSLetters .orgCalcium release-activated calcium (CRAC) channels mediate
the b2-adrenergic regulation of Na,K-ATPasehttp://dx.doi.org/10.1016/j.febslet.2014.10.041
0014-5793/ 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
⇑ Corresponding author at: Division of Pulmonary and Critical Care Medicine,
Department of Medicine, 240 E. Huron Ave., McGaw Mezzanine, Chicago, IL 60611,
USA. Fax: +1 (312) 503 0411.
E-mail address: e-lecuona@northwestern.edu (E. Lecuona).Michael J. Keller a, Emilia Lecuona a,⇑, Murali Prakriya b, Yuan Cheng a, Saul Soberanes a,
G.R. Scott Budinger a, Jacob I. Sznajder a
aDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA
bDepartment of Molecular Pharmacology and Biological Chemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA
a r t i c l e i n f o a b s t r a c tArticle history:
Received 27 June 2014
Revised 23 October 2014
Accepted 29 October 2014
Available online 11 November 2014
Edited by Maurice Montal
Keywords:
Calcium channel
Calcium signaling
Store-operated calcium entry
Epithelial cell
Na,K-ATPaseb2-Adrenergic agonists have been shown to regulate Na,K-ATPase in the alveolar epithelium by
recruiting Na,K-ATPase-containing vesicles to the plasma membrane of alveolar epithelial cells
(AEC). Here, we provide evidence that b2-agonists induce store-operated calcium entry (SOCE) in
AECs. This calcium entry is necessary for b2-agonist-induced recruitment of Na,K-ATPase to the
plasma membrane of AECs. Speciﬁcally, we show that b2-agonists induce SOCE via stromal
interaction molecule 1 (STIM1)-associated calcium release-activated calcium (CRAC) channels. We
also demonstrate that the magnitude of SOCE affects the abundance of Na,K-ATPase at the plasma
membrane of AECs.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In patients with acute lung injury (ALI) and acute respiratory
distress syndrome (ARDS), there is ﬂuid accumulation in the alveoli
and impaired gas exchange, in part due to the decreased ability of
the lungs to clear edema [1,2]. It is well known that alveolar ﬂuid
reabsorption occurs mainly by active transport of sodium ions out
of the alveolar spaces with water following the osmotic gradient
[3]. Sodium transport across the epithelium is regulated in part
by the basolateral Na,K-ATPase in addition to apical sodium chan-
nels and possibly chloride channels [4,5]. Previous studies in ani-
mal models of ARDS demonstrated enhanced alveolar ﬂuid
clearance (AFC) following treatment with b-agonists [6–9]. The
increase in AFC is mediated through the b2-receptor and is due in
large part to recruitment of the Na,K-ATPase to the plasma mem-
brane and consequent increased Na,K-ATPase activity [7,10–13].
Calcium is a second messenger that is important in regulating
vesicle fusion and exocytosis in many cell types [14], and
b2-agonists have been shown to increase intracellular calcium
levels in cardiac myocytes [15,16]. One of the primary modes ofcalcium entry in non-excitable cells is store-operated calcium
entry (SOCE). SOCE consists of two phases: release of Ca2+ from
intracellular stores (mainly the endoplasmic reticulum), which
then leads to a second phase of sustained Ca2+ entry across the
plasma membrane through store-operated channels [17,18]. The
most common and well described mechanism of SOCE occurs via
calcium release-activated calcium (CRAC) channels [19]. CRAC
channels have two key components which are the calcium-sensing
ER transmembrane protein STIM1 and the plasma membrane pore
forming Orai proteins [20].
In this work, we found that b2-agonists elicit SOCE via
STIM1-associated CRAC channels in alveolar epithelial cells (AEC).
In addition, we show that b2-agonist induced calcium entry is nec-
essary for the b2-agonist-induced recruitment of Na,K-ATPase to
the plasma membrane of AECs. Finally, we demonstrate that the
magnitude of calcium entry in AECs impacts the abundance of
Na,K-ATPase at the plasma membrane.2. Materials and methods
2.1. Reagents
All cell culture reagents were from Corning Life Sciences.
Albuterol sulfate (0.083%) vials from Nephron Pharmaceuticals
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Fig. 1. b2-Adrenergic stimulation elicits a rapid increase in intracellular calcium that is required for the recruitment of the Na,K-ATPase to the plasma membrane in alveolar
epithelial cells. Measurement of intracellular calcium concentration in ATII (A) and RLE (B) cells at baseline and following the addition of albuterol (5 lM) to the media. Peak
[Ca2+]i (C) and rate of Ca2+ entry (D) were measured in ATII and RLE cells after addition of 5 lM albuterol. Plasma membrane abundance of Na,K-ATPase was measured via
biotinylation technique in ATII (E) and RLE (F) cells after treatment with albuterol (5 lM, 15 min) in control conditions and in cells pretreated with BAPTA (50 lM, 5 min
pretreatment). Whole-cell lysate Na,K-ATPase was used as a loading control. Results are for 5 experiments with 10–20 cells each. ⁄P < 0.05.
M.J. Keller et al. / FEBS Letters 588 (2014) 4686–4693 4687Corporation were purchased through the Northwestern Memorial
Hospital pharmacy store. 1,2-Bis(2-aminophenoxy)ethane-N,N,N0,
N0-tetraacetic acid-acetoxymethyl ester (BAPTA-AM), thapsigargin
(TG), and lanthanum (III) chloride were from Sigma–Aldrich.
Forskolin was obtained from Ascent Scientiﬁc. ICI-118,551 and
SQ-22536 were from EMD-Millipore. Rat STIM1 small interfering
RNA (siRNA) modiﬁed with 30-AlexaFluor546 was purchased from
Qiagen. Non-silencing siRNA and Lipofectamine RNAiMAX were
from Life Technologies. EZ-Link N-hydroxysuccinimide-SS-biotin
and streptavidin-agarose beads were purchased from Thermo
Scientiﬁc Pierce Protein Biology. All other chemicals were from
Sigma–Aldrich and were the highest grade available.2.2. Cell lines and culture
Alveolar type II (ATII) cells were isolated from the lungs of
pathogen-free adult male Sprague–Dawley rats (200–225 g), as
described previously [21]. Cells were used on days 2 and 3 after
the isolation. Rat lung epithelial (RLE-6TN) cells (ATCC CRL-2300)
were grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum, 100 U/ml penicillin,
100 lg/ml streptomycin, and 20 lM HEPES.
2.3. Transfections
RLE cells were transfected with rat STIM1 siRNA duplexes
(100 pmol) by using Lipofectamine RNAiMAX according to the
manufacturer’s recommended protocol, and experiments were
performed 48–72 h later. A nonsilencing siRNA was used as a
control.2.4. Measurement of intracellular calcium
ATII or RLE cells plated on 40-mm coverslips were loaded with
fura-2-acetoxymethyl ester (Fura2-AM) (Life Technologies) for
30 min at room temperature in standard buffer solution (150 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM glucose, 25 mM sodium
bicarbonate, and either 2.5 mM CaCl2 or 0.25 mM EGTA pH 7.4)
in the dark, washed with PBS, and further incubated for 30 min
at room temperature to complete deesteriﬁcation of the dye. Fura2
dye was excited through 340-nm and 380-nm interference ﬁlters
housed in a computer-controlled wheel. The ﬂuorescence emitted
was collected at 510 nm. The data acquisition of Fura2 video imag-
ing was obtained using a Nikon TE2000 (Nikon Instruments Inc.)
equipped with an environmental control system chamber (FCS2
system; Bioptechs Inc.) and a Plan Super Fluor 40 oil objective
(Nikon Instruments Inc.). Images were collected with a Cascade
electron-multiplying charge-coupled device (EMCCD) camera
TC285 with on-chip multiplication gain (Photometrics) drien by
MetaFluor software (Molecular Devices Corp.). Changes in calcium
concentration were obtained from the F340/F380 ratio and expressed
as nM concentrations. To convert Fura2 ﬂuorescence measure-
ments, a calcium imaging calibration kit (Life Technologies) was
used to generate a titration standard curve. Drugs were perfused
to the cells using a pumping system with tubes equipped with
stopcocks.2.5. Biotinylation of cell surface proteins
Cells were labeled for 20 min at 4 C using 1 mg/ml EZ-Link
N-hydroxysuccinimide-SS-biotin and lysed in cell lysis buffer from
Cell Signaling as previously described [22,23]. Surface proteins
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Fig. 2. Alveolar epithelial cells lack measurable voltage-gated calcium channel activity, but demonstrate store-operated calcium entry in response to thapsigargin and
b2-agonists. (A) Measurement of intracellular calcium concentration in ATII cells during the addition of a depolarizing concentration of KCl (65 mM), followed by the addition
of thapsigargin (1 lM) in media lacking calcium. 2.5 mM calcium was then re-instituted into the media as indicated. (B) Levels of intracellular calcium in ATII cells during the
addition of albuterol (5 lM) to calcium-free media, followed by the return of calcium to the perfusing media. Results are for 5 experiments with 10–20 cells each. (C) Peak
[Ca2+]i and (D) rate of Ca2+ entry were measured in the cells after re-institution of 2.5 mM calcium to the media. Results are for 3 experiments with 10–20 cells each.
⁄⁄⁄⁄P < 0.0001; ⁄⁄⁄P < 0.001. TG: Thapsigargin. Alb: Albuterol. V: vehicle.
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by sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) and Western blotting.
2.6. Cell lysis and Western blot analysis
After treatment, ATII and RLE cells were washed in ice-cold
phosphate-buffered saline (PBS) and solubilized in cell lysis buffer
(Cell Signaling). The lysates were cleared by centrifugation for
10 min at 14000g. Protein concentrations were determined by
the Bradford assay using a commercial dye reagent (Bio-Rad),
and samples containing equal amounts of protein were separated
by SDS–PAGE and transferred onto nitrocellulose membranes (GE
Healthcare Life Sciences) by using a Trans-Blot Turbo (Bio-Rad)
transfer system. The following commercially available antibodies
and dilutions were used for Western blotting: mouse anti-Na,K-
ATPase subunit a1 (clone 464.6; 1:10000) was from EMD Milli-
pore; rat anti-STIM1 (1:1000) was from Cell Signaling Technology.
Primary antibodies were detected with horseradish peroxidase-
conjugated secondary goat anti-mouse antibodies (1:10000; Bio-
Rad) or goat anti-rabbit antibodies (1:2000; Cell Signaling Technol-
ogy) by using a chemiluminescence detection kit (Perkin-Elmer
Life Sciences). Quantiﬁcation of protein levels was performed by
densitometric scanning with ImageJ 1.29X (NIH).
2.7. Statistics
Data are presented as means ± standard errors of the means
(S.E.M.) and were statistically analyzed using unpaired t-test or
one-way analysis of variance (ANOVA) followed by a multiplecomparison (Dunnett) test. P values of less than 0.05 were consid-
ered statistically signiﬁcant.
3. Results
3.1. b2-Adrenergic stimulation elicits a rapid increase in intracellular
calcium in alveolar epithelial cells
To determine if b2-adrenergic receptor activation results in cal-
cium entry in alveolar epithelial cells, we stimulated ATII epithelial
cells and RLE cells with albuterol, a selective b2-receptor agonist.
Measurements of calcium concentrations in both cell types
revealed a rapid increase in intracellular calcium immediately fol-
lowing the application of albuterol to the media (Fig. 1A and B).
The peak [Ca2+]i (Fig. 1C) as well as the Ca2+ inﬂux (represented
as D[Ca2+]/Dt, [24,25]) was very similar in both cell types (Fig. 1D).
3.2. Calcium is necessary for the b2-agonist-induced recruitment of
Na,K-ATPase to the plasma membrane of alveolar epithelial cells
Our previous work demonstrated that b2-adrenergic receptor
activation leads to increased abundance of Na,K-ATPase at the
plasmamembrane of AECs [7,10]. To determine if calciumwas nec-
essary for the b2-agonist-induced recruitment of Na,K-ATPase to
the plasma membrane of AECs, we pretreated both ATII epithelial
cells and RLE cells with BAPTA, a chelator of intracellular and
extracellular calcium, prior to stimulation with albuterol. As shown
in Fig. 1E and F, BAPTA prevented the b2-agonist-induced
recruitment of Na,K-ATPase to the plasma membrane of both cell
types.
M.J. Keller et al. / FEBS Letters 588 (2014) 4686–4693 46893.3. Alveolar epithelial cells exhibit store-operated calcium entry
(SOCE)
In non-excitable cells, the most common route of calcium signal
generation results from activation of cell surface receptors which
leads to emptying of intracellular calcium stores, followed by cal-
cium entry into the cell via SOCE channels [17,18]. Other common
mode of calcium inﬂux involves voltage-gated calcium channels
that respond to depolarization and play a signiﬁcant role in cal-
cium signaling in excitable cells [16]. We observed that ATII epi-
thelial cells lack signiﬁcant voltage-gated calcium channel
activity when stimulated with a depolarizing concentration of
potassium chloride, but elicit a robust response to thapsigargin, a
non-competitive inhibitor of sarco/endoplasmic reticulum Ca2+
ATPase and a powerful stimulus of SOCE (Fig. 2A). In a similar fash-
ion, we found that albuterol triggered the release of intracellular
calcium stores when calcium levels were measured in media
lacking calcium, and that SOCE occurred when calcium was
returned to the perfusing media (Fig. 2B). Noteworthy, albuterol
caused a milder inﬂux of Ca2+ in alveolar epithelial cells than
thapsigargin reﬂected in the peak [Ca2+]i (Fig. 2C) and the rate of
Ca2+ inﬂux (Fig. 2D) [26].
3.4. STIM1-associated CRAC channels mediate albuterol-induced SOCE
and recruitment of Na,K-ATPase to the plasma membrane
STIM1 is a transmembrane protein that functions as a calcium
sensor in the ER that is responsible for communicating depletion
of ER calcium stores to Orai channels in the plasma membrane0 mM Ca2+ 2.5 mM Ca2+
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calcium in RLE cells transfected with ﬂuorescently labeled siRNA against STIM1 during ex
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5 min preincubation) or transfected with siRNA against STIM1 previous addition of albut
15 min treatment) in control conditions and following a 5 min pretreatment with LaCl3
(5 lM, 15 min) in RLE cells transfected with scramble siRNA or siRNA targeting STIM1
experiments with 10–20 cells each. ⁄P < 0.05, ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001.[18,19]. Calcium entry via CRAC channels can be inhibited various
ways, including binding of the channel with lanthanum chloride
(LaCl3). We showed that pre-treating ATII epithelial cells with LaCl3
blunted the degree of calcium entry seen after albuterol is applied
to the cells (Fig. 3A), as well as the peak [Ca2+]i (Fig. 3C) and the
rate of Ca2+ inﬂux (Fig. 3D). We also demonstrated that CRAC chan-
nel inhibition with LaCl3 abrogated the increase in Na,K-ATPase
protein abundance at the plasma membrane following stimulation
with albuterol (Fig. 3E). Transfecting RLE cells with siRNA targeting
STIM1 tagged with a ﬂuorescent dye (AlexaFluor546) allowed for
selection of transfected cells during calcium measurements. We
showed that calcium entry in response to albuterol was blocked
or blunted in cells transfected with siRNA targeting STIM1 com-
pared to those cells that were not transfected (Fig. 3B; 80% trans-
fection efﬁciency), as well as the peak [Ca2+]i (Fig. 3C) and the rate
of Ca2+ inﬂux (Fig. 3D). In addition, silencing STIM1 via siRNA pre-
vented the albuterol-induced recruitment of Na,K-ATPase to the
plasma membrane (Fig. 3F).
3.5. Activation of adenylyl cyclase results in SOCE
Binding of an agonist to the b2-adrenergic receptor results in
dissociation of the Gsa subunit of the G protein and activation of
adenylyl cyclase with subsequent increase in cAMP levels and
downstream signaling [27]. We ﬁrst conﬁrmed the speciﬁcity of
albuterol as a b2-agonist by inhibiting the effect of albuterol in cal-
cium entry by pre-incubation with 1 lM of the b2-antagonist ICI-
118,551 (Fig. 4A, D and E). The role of cAMP on SOCE was deter-
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(Fig. 4B, D and E). We also found that direct activation of adenylyl
cyclase by forskolin resulted in SOCE with similar magnitude of
peak calcium but with an increased rate of calcium entry as that
seen with albuterol (Fig. 4C, D and E). In addition, we showed that
forskolin-induced calcium entry is inhibited in RLE cells transfec-
ted with siRNA targeting STIM1 and tagged with a ﬂuorescent
dye (AlexaFluor546) (Fig. 4F).
3.6. The magnitude of SOCE affects the abundance of Na,K-ATPase at
the plasma membrane of AECs
Previous work in our lab has demonstrated that treatment of
A549 cells with 1 lM thapsigargin results in signiﬁcant endocyto-
sis of Na,K-ATPase [28]. In attempt to explain why a different
stimulus, albuterol, that also elicits SOCE results in recruitment
of Na,K-ATPase to the plasma membrane, we compared the effect
of treatment with different concentrations of thapsigargin on
plasma membrane Na,K-ATPase abundance. We showed that a
concentration of 1 nM thapsigargin results in SOCE of similar
magnitude as albuterol (Fig. 5A) as well as similar peak [Ca2+]i
(Fig. 5B) and rate of Ca2+ inﬂux (Fig. 5C). We also found that only
high concentrations of thapsigargin result in endocytosis of the
Na,K-ATPase, whereas lower concentrations have no signiﬁcant
effect on the abundance of Na,K-ATPase at the plasma membrane
(Fig. 5D). These results suggest that both calcium and cAMP are
necessary for the b2-agonist induced recruitment of Na,K-ATPase
to the plasma membrane in AECs.4. Discussion
Previous in vitro and animal studies have shown that b-agonists
enhance alveolar ﬂuid clearance, and this effect is mediated in part
by increased abundance of Na,K-ATPase at the plasma membrane
of AECs [6–11,28]. In this work, we demonstrated that b2-agonists
elicit store-operated calcium entry (SOCE) in AECs, and this cal-
cium entry is necessary for the b2-agonist induced upregulation
of Na,K-ATPase at the plasma membrane. Speciﬁcally, we showed
that SOCE via STIM1-associated CRAC channels is involved in the
response. We demonstrated that calcium entry is necessary, but
not sufﬁcient for the b2-agonist-induced recruitment of Na,K-ATP-
ase to the plasma membrane of alveolar epithelial cells. Finally, we
showed that the magnitude of SOCE independently affected the
abundance of Na,K-ATPase at the plasma membrane of AECs.
SOCE has been reported in AECs [29–31], but this is the ﬁrst
report of b2-agonists eliciting SOCE in AECs. Calcium is an impor-
tant component of vesicle fusion and exocytosis in neurons as well
as endocrine cells and T-cells [14]. Both cAMP and calcium are rec-
ognized to play important independent as well as cooperative roles
in exocytosis in non-neuronal cells [32]. Within alveolar cells,
cAMP promotes the recruitment of Na,K-ATPase from intracellular
vesicle pools into the plasma membrane [33,34]. By chelating
calcium with BAPTA, we showed that calcium was also necessary
for the b2-agonist-induced recruitment of Na,K-ATPase to the
plasma membrane.
STIM1 is the primary calcium sensing protein in the ER and a
major component of CRAC channels along with the Orai family of
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CRAC channels and STIM1, we showed that the b2-agonist induced
SOCE is mediated by STIM1-containing CRAC channels. In addition
to its role in CRAC channels, STIM1 has been shown to activate
adenylyl cyclase and increase cAMP following calcium store deple-
tion in a process which is independent of cytosolic calcium [35].
This process of store-operated cAMP signaling may also be contrib-
uting in a regulatory mechanism to the b2-agonist induced SOCE
and recruitment of Na,K-ATPase to the plasma membrane of alve-
olar epithelial cells. STIM1 has also been shown to bind to Na,K-
ATPases through a STIM1-POST (partner of STIM1) complex that
is triggered by intracellular store depletion [36]. This raises the
possibility that STIM1 may have a direct stabilization effect on
Na,K-ATPase abundance at the plasma membrane and contribute
directly to the b2-agonist induced response.
Activation of b2-agonist receptors leads to dissociation of the
Gsa subunit of the G protein and activation of adenylyl cyclase with
subsequent increase in cAMP levels. In this work, we show that for-
skolin elicits SOCE in AECs of similar magnitude as albuterol, indi-
cating that the Gsa subunit/adenylyl cyclase and increased cAMP
mediate the b2-agonist induced SOCE; and we conﬁrmed this
observation by preventing SOCE in cells treated with albuterol in
the presence of the adenylyl cyclase inhibitor SQ22536. We
hypothesize that cAMP by a still not determined mechanism stim-
ulate the increase in intracellular calcium, a phenomenon that
might be cell speciﬁc as cAMP does not have a direct effect on
increasing intracellular calcium in kidney cells [37]. A similar
interaction between cAMP and calcium entry has been shown toregulate prostaglandin E2-mediated chloride secretion in mouse
inner medullary collecting duct cells [38]. Inhibiting STIM1 with
a ﬂuorescently labeled siRNA conﬁrms the role of STIM1-associ-
ated CRAC channels in the cAMP-mediated SOCE.
We have previously demonstrated that robust SOCE elicited by
1 lM thapsigargin results in endocytosis of the Na,K-ATPase in
alveolar epithelial cells [28]. However, albuterol causes SOCE of
signiﬁcantly lower magnitude and similar to that of a lower dose
(1 nM) of thapsigargin. We showed that low magnitude SOCE does
not have signiﬁcant effect on the abundance of Na,K-ATPase at the
plasma membrane and supports the statement that calcium is nec-
essary but not sufﬁcient for the b2-agonist induced recruitment of
Na,K-ATPase. We have previously demonstrated that PKA is also
necessary for the b2-adrenergic-induced recruitment of the
Na,K-ATPase to the plasma membrane [12,13]; therefore, we
hypothesize that cAMP by increasing intracellular Ca2+ and activat-
ing PKA leads to the recruitment of the Na,K-ATPase in alveolar
epithelial cells. There are numerous potential sites of crosstalk
between cAMP and calcium signaling within non-excitable cells
that may impact the spatio-temporal pattern of calcium signaling
[39]. We hypothesize that compartmentalized cAMP signaling in
concert with mild increases in calcium levels, likely in spatially
related microdomains, work together to augment the recruitment
of Na,K-ATPase from intracellular vesicles to the plasmamembrane
of alveolar epithelial cells.
In summary, as shown schematically in Fig. 6, we have shown
that calcium entry via STIM1-associated CRAC channels is neces-
sary for the recruitment of Na,K-ATPase to the plasma membrane
β2AR ACTM ATP
cAMP
ER
Ca2+
ER
STIM1
Ca2+
NKA
STIM1
NKA
NKA
NKA
NKA
NKA
CRAC
Fig. 6. Schematic representation of b2 agonist-induced SOCE and recruitment of
Na,K-ATPase vesicles to the plasma membrane of alveolar epithelial cells. b2AR
(b2-adrenergic receptor), AC™ (transmembrane adenylyl cyclase), NKA (Na,K-ATPase).
4692 M.J. Keller et al. / FEBS Letters 588 (2014) 4686–4693of ATII epithelial cells following treatment with albuterol and the
subsequent increase in cAMP. These ﬁndings may allow for further
investigations into therapeutic options to enhance alveolar ﬂuid
clearance in patients with ARDS.
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